Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
Maharaj K, Powers JJ, Achille A, Deng S, Fonseca R, Pabon-Saldana M, Quayle SN, Jones SS, Villagra A, Sotomayor EM, Sahakian E, Pinilla-Ibarz J.
Maharaj K, et al. Among authors: quayle sn.
Blood Adv. 2018 Nov 13;2(21):3012-3024. doi: 10.1182/bloodadvances.2018020065.
Blood Adv. 2018.
PMID: 30425065
Free PMC article.